Connection
Tobias De La Garza Eckle to Midazolam
This is a "connection" page, showing publications Tobias De La Garza Eckle has written about Midazolam.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.405 |
|
|
|
-
Oyama Y, Bartman CM, Gile J, Sehrt D, Eckle T. The Circadian PER2 Enhancer Nobiletin Reverses the Deleterious Effects of Midazolam in Myocardial Ischemia and Reperfusion Injury. Curr Pharm Des. 2018; 24(28):3376-3383.
Score: 0.262
-
Gile J, Oyama Y, Shuff S, Eckle T. A Role for the Adenosine ADORA2B Receptor in Midazolam Induced Cognitive Dysfunction. Curr Pharm Des. 2020; 26(34):4330-4337.
Score: 0.075
-
Gile J, Scott B, Eckle T. The Period 2 Enhancer Nobiletin as Novel Therapy in Murine Models of Circadian Disruption Resembling Delirium. Crit Care Med. 2018 06; 46(6):e600-e608.
Score: 0.067